Picture of Totally logo

TLY Totally News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

REG - Totally PLC Oryx Int. Growth Fnd - Holding(s) in Company




 



RNS Number : 8996L
Totally PLC
15 January 2021
 

TR-1: Standard form for notification of major holdings

 

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

TOTALLY PLC

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

Harwood Capital Management (Gibraltar) Limited (as investment adviser/manager)  to 1.Oryx International Growth Fund Limited 

and Harwood Capital LLP (as investment advisor/manager) to 2. Harwood Capital LLP

City and country of registered office (if applicable)

1.   Guernsey

2.   London, United Kingdom

 

4. Full name of shareholder(s) (if different from 3.)v

Name

1.   Oryx International Growth Fund Limited

2.   Harwood Capital LLP

 

City and country of registered office (if applicable)

As above

5. Date on which the threshold was crossed or reachedvi:

14 January 2021

6. Date on which issuer notified (DD/MM/YYYY):

15 January 2021

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

1. 4.39%

2. 0.21%

 

 

 

1. 4.39%

2. 0.21%

 

182,186,111

Position of previous notification (if

applicable)

1. 5.49%

2. 0.21%

 

 

 

 

1. 5.49%

2. 0.21%

 

 

 

 

             

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type of
shares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

 

GB00BYM1JJ00

 

8,000,000

   380,000

 

 

4.39%

0.21%

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

8,380,000

4.60%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expiration
date
x

Exercise/
Conversion Period
xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expiration
date
x

Exercise/
Conversion Period
xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

                   

 

 

Place of completion

London

Date of completion

15 January 2021

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLDKPBDNBKDCDD

Recent news on Totally

See all news